Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN003736 | 60.9747 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 75.9981 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 75.9983 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 92.0294 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 92.0295 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 92.9643 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 92.9645 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 94.0269 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 94.0416 | 2.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 97.9674 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 100.0888 | 2.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 120.053 | 2.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 120.0558 | 6.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 128.1195 | 4.09 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 128.1199 | 3.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 135.9016 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 135.9648 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 136.0512 | 0.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 137.096 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 140.0473 | 4.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 142.0992 | 2.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 142.1355 | 4.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 144.1147 | 4.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 150.0165 | 6.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 150.017 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 152.0124 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 155.0708 | 4.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 156.1513 | 4.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 159.0678 | 2.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 160.8997 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 164.0464 | 1.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 166.0478 | 6.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 168.0458 | 6.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 170.1669 | 5.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 170.1672 | 5.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 174.1248 | 3.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 177.9023 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 182.0697 | 2.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 182.0725 | 5.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 184.0186 | 6.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 184.0193 | 5.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 184.0195 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 184.1462 | 4.57 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 185.0253 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 185.0253 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 185.0259 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 187.12 | 2.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 188.1404 | 3.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 191.0605 | 0.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 193.055 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 193.1228 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 193.1229 | 4.6 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 194.0942 | 4.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 194.1668 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 194.1669 | 5.21 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 195.9132 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 196.1461 | 4.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 196.1463 | 4.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 198.1617 | 4.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 198.1982 | 6.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 198.1985 | 5.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 199.1929 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 200.1776 | 5.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 206.168 | 6.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 208.0046 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 208.0186 | 1.99 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 208.146 | 4.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 210.1621 | 4.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 210.1621 | 4.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 212.1414 | 4.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 212.1415 | 4.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 212.2139 | 6.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 214.1561 | 4.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 214.1933 | 5.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 215.1519 | 3.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 216.1726 | 4.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 218.1514 | 4.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 218.1518 | 4.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 220.1819 | 4.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 222.0567 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 222.162 | 5.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.035 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.0353 | 3.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.0353 | 5.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.0356 | 5.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.0358 | 2.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.037 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 224.1088 | 4.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.0148 | 3.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.0153 | 2.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.0155 | 3.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.0162 | 4.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.0344 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.1568 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.157 | 4.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 226.23 | 6.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 228.2091 | 6.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 229.1679 | 3.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 229.1679 | 3.38 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 230.1521 | 3.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 230.1671 | 5.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 230.1876 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 232.1696 | 4.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 234.1628 | 5.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 240.0743 | 5.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 240.1353 | 4.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 242.0509 | 2.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 242.1522 | 4.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 242.1551 | 4.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 243.1836 | 6.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 243.1837 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 243.184 | 7.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 243.1843 | 7.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 248.1774 | 4.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 248.1781 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 248.1781 | 5.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 250.1567 | 5.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 250.1936 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 252.1039 | 3.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 254.2249 | 7.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 254.261 | 7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 254.2619 | 7.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 257.1992 | 4.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 257.2002 | 5.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 258.22 | 5.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 265.1669 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 266.1562 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 266.1893 | 4.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 270.0947 | 3.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 270.1297 | 4.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 270.2929 | 9.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 271.2147 | 4.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 272.2359 | 6.6 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 273.1719 | 3.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 273.1729 | 3.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 273.1733 | 3.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 273.8911 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 274.1778 | 4.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 276.1725 | 4.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 276.1758 | 5.99 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 277.1688 | 6.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 278.1526 | 5.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 278.1886 | 4.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.1702 | 6.05 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.1705 | 5.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.1708 | 6.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.2035 | 5.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.2402 | 5.41 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.2405 | 5.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 280.2412 | 7.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 282.023 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 282.1479 | 5.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 282.2517 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 282.2565 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 284.1071 | 4.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 284.1452 | 5.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 284.2499 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 284.2718 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 285.994 | 2.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 287.1888 | 3.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 288.2304 | 4.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 290.1113 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 292.2035 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 294.1838 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 294.1846 | 5.21 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 294.1867 | 6.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 295.1056 | 5.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 296.2348 | 5.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 296.2349 | 6.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.0542 | 4.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.0548 | 4.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.0548 | 4.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.1258 | 4.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.1618 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 298.2509 | 5.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 300.0344 | 3.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 300.2673 | 6.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 301.0529 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 301.1622 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 302.0114 | 3.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 302.0127 | 2.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 302.1289 | 4.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 302.2245 | 5.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 302.2249 | 6.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 303.1477 | 3.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 304.1879 | 3.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 304.24 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 304.2403 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 304.2409 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 306.2562 | 7.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 306.2564 | 7.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 308.1202 | 2.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 310.1792 | 4.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 310.1828 | 6.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 312.1423 | 5.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 314.0862 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 314.0866 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 314.1859 | 5.51 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 314.2462 | 5.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 315.1784 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 316.2617 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 317.0853 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 317.1634 | 3.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 318.147 | 5.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 320.1092 | 4.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 320.1667 | 4.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 322.2195 | 8.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 323.2238 | 8.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 324.8178 | 11.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 326.1932 | 6.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 328.1374 | 6.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 328.2371 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 328.242 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 329.1928 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 329.194 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 330.0933 | 4.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 330.2401 | 3.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 330.2545 | 5.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 330.2564 | 7.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 330.2569 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 331.179 | 3.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 332.2715 | 7.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 334.1003 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 334.1004 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 334.1439 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 335.1744 | 6.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 336.1967 | 6.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 338.1742 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 338.214 | 7.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 338.2141 | 7.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 339.2518 | 2.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 340.297 | 6.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 342.1507 | 7.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 342.1511 | 7.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 342.1869 | 4.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 342.1875 | 5.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 342.2896 | 4.38 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 343.3093 | 5.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 344.2203 | 4.88 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 344.3042 | 4.38 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 345.1937 | 4.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 347.3034 | 5.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 348.2289 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 350.2454 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 350.2511 | 10.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 351.1339 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 352.1423 | 4.6 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 352.1911 | 4.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 353.0872 | 4.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 354.0563 | 2.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 354.1524 | 7.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 354.209 | 6.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.0375 | 4.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.1204 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.1208 | 5.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.1672 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.202 | 5.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 356.2732 | 7.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 357.1379 | 6.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 358.0224 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 358.2828 | 4.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 358.2831 | 3.99 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 359.2104 | 4.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 360.0138 | 4.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 360.014 | 4.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 361.2818 | 4.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 361.9817 | 3.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 362.1714 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 362.2554 | 2.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 363.2451 | 6.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 366.1269 | 3.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 366.1493 | 5.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 366.1493 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 366.2433 | 9.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 368.1681 | 7.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 368.2495 | 7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.135 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.1361 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.1833 | 7.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.1833 | 7.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.214 | 6.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.307 | 7.12 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 370.3452 | 9.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 372.1815 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 372.2517 | 5.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 374.0523 | 6.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 374.0524 | 5.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 374.0534 | 4.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 374.0534 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 374.245 | 7.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 376.0389 | 2.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 378.2085 | 4.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 380.1645 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 380.1665 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 380.1674 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 380.1859 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 381.1683 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 381.9826 | 2.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 382.1825 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 382.1826 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 382.235 | 7.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 382.346 | 7.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 383.1395 | 5.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 384.1521 | 6.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 384.1981 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 384.2169 | 4.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 384.3068 | 8.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 384.3605 | 9.99 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 385.2835 | 6.41 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 386.2009 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 388.9671 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 389.1647 | 5.85 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 389.2192 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 389.9741 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 391.2787 | 8.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 391.3316 | 5.38 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 393.2699 | 5.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 394.1807 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 394.1812 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 394.2378 | 4.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 394.2558 | 5.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 395.1628 | 6.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 396.1168 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 396.1979 | 8.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 396.2308 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 396.2561 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 396.2563 | 4.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 397.1534 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 397.1554 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 398.0901 | 5.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 398.2352 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 398.244 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 398.3749 | 10.41 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 399.2723 | 5.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 400.2862 | 6.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 401.1629 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 402.0899 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 402.0964 | 3.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 402.1582 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 402.2181 | 3.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 403.3097 | 4.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 404.1663 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 406.0188 | 4.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 406.1877 | 7.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 407.1225 | 6.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 407.3162 | 6.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 407.3163 | 5.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 408.1957 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 408.276 | 7.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 410.1092 | 6.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 410.2138 | 8.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 410.3186 | 7.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 410.3205 | 9.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 411.1705 | 6.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 411.1705 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 411.1824 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.0885 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.1017 | 6.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.1026 | 6.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.2441 | 4.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.2468 | 4.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 412.3915 | 10.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 413.2155 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 414.0117 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 415.3301 | 6.21 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 415.3301 | 6.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 416.1959 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 416.2562 | 5.99 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 416.2582 | 5.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 416.3265 | 5.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 417.1503 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 418.2355 | 4.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 420.2875 | 5.21 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 420.2879 | 5.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 422.1948 | 6.51 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 422.2355 | 6.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 423.1773 | 7.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 423.2738 | 5.6 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 425.1837 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 426.1185 | 6.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 426.1199 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 426.267 | 8.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 427.2732 | 7.6 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 427.976 | 4.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 428.1185 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 428.1193 | 6.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 428.1682 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 428.2928 | 5.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 428.3267 | 7.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.0892 | 4.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.1796 | 7.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.1824 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.1905 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.1906 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 430.3076 | 4.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 432.1949 | 7.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 432.2493 | 5.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 433.1692 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 434.0251 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 434.137 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 434.1936 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 434.3393 | 6.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 434.3411 | 7.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 435.1836 | 7.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 437.2613 | 8.57 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 437.2919 | 5.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 438.274 | 6.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 438.3526 | 8.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 439.1846 | 6.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 439.2232 | 5.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 440.123 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 440.1337 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 440.2158 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 442.1348 | 6.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 442.136 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 442.2134 | 8.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 442.2598 | 6.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 444.358 | 5.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 448.1518 | 6.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 449.3149 | 4.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 449.3155 | 4.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 450.2274 | 7.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 451.2683 | 5.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 451.2709 | 5.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 452.1191 | 5.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 452.3369 | 2.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 453.2855 | 5.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 453.2872 | 5.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 454.189 | 7.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 456.0019 | 4.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 456.11 | 4.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 456.1108 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 456.1513 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 457.1696 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 459.0084 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 459.1861 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 459.2476 | 4.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 459.429 | 7.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 460.3364 | 8.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 461.1681 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 462.1687 | 6.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 462.1689 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 462.9865 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 463.307 | 6.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 464.1702 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 464.2156 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 465.3096 | 4.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 465.3231 | 6.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 466.2235 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 467.1615 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 467.3048 | 6.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 467.3085 | 5.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 468.151 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 468.2717 | 4.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 469.19 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 470.3731 | 4.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 472.1254 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 472.2759 | 9.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 474.2908 | 10.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 474.2909 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 474.3169 | 7.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 474.3192 | 6.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 475.2439 | 4.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 475.3887 | 6.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 477.2865 | 5.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 477.2871 | 5.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 479.3025 | 5.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 479.3028 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 480.0378 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 480.1274 | 7.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 480.2026 | 7.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 481.3169 | 5.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 481.3172 | 6.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 481.3183 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 482.2159 | 6.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 482.3421 | 7.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 483.1498 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 483.2155 | 6.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 483.3021 | 4.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 484.1782 | 3.21 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 484.2865 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 484.9549 | 4.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 486.1412 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 486.1426 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 486.2802 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 486.2849 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 487.1457 | 6.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 490.286 | 11.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 491.1782 | 7.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 491.3088 | 6.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 491.3364 | 6.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 493.3524 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 493.3558 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 493.3563 | 7.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 495.1272 | 3.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 496.1624 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 496.3546 | 7.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 498.175 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 499.2693 | 5.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 500.1583 | 6.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 500.1586 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 500.3084 | 9.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 501.2409 | 6.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 501.2864 | 10.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 501.2865 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 502.2236 | 3.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 503.3034 | 5.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 504.0916 | 4.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 505.2793 | 5.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 505.3168 | 5.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 507.1536 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 507.3326 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 507.3331 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 508.0663 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 509.1688 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 509.3481 | 6.37 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 509.4826 | 10.36 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 510.2497 | 6.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 510.2946 | 6.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 511.327 | 5.57 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 513.3055 | 5.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 515.1761 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 515.2827 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 515.29 | 3.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 516.1362 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 516.1401 | 6.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 518.1006 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 520.1596 | 7.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 521.2762 | 5.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 521.389 | 7.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 522.1143 | 5.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 523.2916 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 523.2917 | 6.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 525.2872 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 525.304 | 6.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 525.308 | 6.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 525.3435 | 5.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 527.3019 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 527.3028 | 5.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 527.3162 | 5.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 527.318 | 5.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 529.29 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 529.3179 | 5.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 529.3191 | 5.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 530.0209 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 530.1565 | 6.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 530.3119 | 7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 531.2949 | 6.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 531.3325 | 6.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 532.2528 | 4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 533.3094 | 6.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 534.2955 | 6.12 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 537.5134 | 11.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 539.3208 | 5.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 539.3239 | 5.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 539.5276 | 11.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 540.0922 | 3.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 540.3113 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 541.339 | 5.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 541.34 | 5.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 544.1625 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 544.1661 | 7.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 545.2737 | 6.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 545.2746 | 5.53 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 545.2756 | 5.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 545.2774 | 5.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 546.127 | 4.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 547.2886 | 6.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 547.2897 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 547.2898 | 5.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 549.3061 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 549.3076 | 6.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 550.1043 | 5.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 550.1045 | 5.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 551.3596 | 6.09 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 551.9893 | 4.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 553.3372 | 5.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 553.3747 | 6.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 553.511 | 10.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 554.2937 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 554.3286 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 555.3517 | 6.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 555.3535 | 5.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 556.2828 | 6.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 558.3357 | 2.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 558.974 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 561.3426 | 7.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 563.3229 | 5.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 564.1204 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 564.1489 | 7.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 565.3385 | 5.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 565.3387 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 565.421 | 2.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 566.1609 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 567.2524 | 5.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 567.3551 | 5.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 567.3564 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 569.2731 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 569.2736 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 569.3716 | 6.37 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 569.5034 | 10.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 570.2778 | 5.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 571.3681 | 6.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 572.2964 | 6.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 572.2984 | 5.84 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 572.3159 | 5.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 572.3576 | 7.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 572.4765 | 10.36 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 573.3063 | 6.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 574.2992 | 4.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 574.3374 | 7.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 576.2774 | 4.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 578.1164 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 581.2411 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 581.3686 | 6.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 581.5039 | 10.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 582.2674 | 7.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 582.5334 | 11.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 583.1925 | 8.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 586.0419 | 3.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 586.2068 | 10.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 586.3002 | 5.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 586.3047 | 5.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 586.4943 | 10.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 587.3207 | 5.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 587.3236 | 5.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 588.3141 | 4.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 589.3392 | 5.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 589.3392 | 5.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 589.3396 | 5.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 590.2084 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 591.3514 | 5.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 591.3544 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 593.2702 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 593.3677 | 6.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 594.2797 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 595.2871 | 5.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 595.3862 | 6.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 596.3003 | 5.77 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 597.5335 | 11.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 598.3118 | 6.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 598.3137 | 6.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 600.3295 | 7.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 600.3629 | 6.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 600.509 | 11.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 601.2108 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 602.3272 | 4.95 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 602.5243 | 11.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 609.3274 | 5.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 609.3276 | 5.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 610.563 | 9.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 611.2574 | 5.9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 612.1489 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 613.3382 | 5.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 613.3402 | 5.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 614.162 | 7.35 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 615.352 | 5.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 615.3547 | 5.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 615.3553 | 5.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 615.3568 | 5.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 616.2968 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 616.36 | 6.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 618.2797 | 5.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 618.2828 | 5.41 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 618.3054 | 5.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 620.2973 | 5.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 622.3147 | 6.09 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 622.3151 | 6.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 623.2804 | 4.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 624.3078 | 5.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 626.0071 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 630.342 | 6.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 633.3271 | 5.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 634.1504 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 635.3428 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 635.343 | 5.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 637.2607 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 637.3571 | 6.37 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 638.3673 | 6.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 642.36 | 6.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 644.2997 | 5.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 644.3018 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 646.3185 | 5.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 647.4347 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 651.0742 | 8.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 653.2688 | 5.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 654.4123 | 7.37 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 654.4137 | 7.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 654.4721 | 9 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 655.4496 | 11.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 656.4263 | 7.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 656.4324 | 10.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 656.4334 | 8.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 657.3286 | 5.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 659.3336 | 6.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 660.5225 | 8.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 660.5249 | 9.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 663.3648 | 6.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 665.0738 | 8.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 666.4384 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 667.6134 | 10.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 670.4065 | 7.12 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 670.4094 | 6.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 671.5344 | 8.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 672.4236 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 672.4243 | 6.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 672.4244 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 672.427 | 8.67 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 673.2306 | 5.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 674.3629 | 6.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 674.3669 | 6.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 675.2507 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 675.2511 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 675.3263 | 6.36 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 681.0835 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 682.4982 | 9.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 684.6021 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 684.6023 | 10.72 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 688.2852 | 5.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 688.4174 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 688.4181 | 6.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 688.5553 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 689.5014 | 9.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 690.5716 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 691.4581 | 8.44 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 693.6283 | 10.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 693.6293 | 10.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 695.4937 | 9.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 697.5335 | 6.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 699.2464 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 699.3966 | 7.37 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 699.5195 | 10.54 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 699.5576 | 9.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 701.267 | 5.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 703.3298 | 5.92 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 705.3445 | 6.38 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 706.5304 | 7.91 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 707.4929 | 9.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 709.5077 | 9.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 709.5293 | 9.36 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 710.6209 | 10.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 712.6624 | 9.1 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 714.3226 | 6.16 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 714.4825 | 2.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 715.3922 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 715.3952 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 715.5162 | 10.07 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 715.5166 | 10.18 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 717.5309 | 11.05 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 719.0308 | 6.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 719.4224 | 7.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 719.4936 | 9.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 720.5443 | 8.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 721.0409 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 721.5074 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 722.5584 | 8.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 723.5137 | 8.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 723.5221 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 733.5068 | 9.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 734.4255 | 6.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 734.4264 | 7.75 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 734.5623 | 8.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 735.4194 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 735.4194 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 735.5235 | 10.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 735.53 | 10.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 737.1464 | 10.57 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 737.5381 | 10.82 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 738.5532 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 739.5184 | 10.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 741.5313 | 10.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 743.5464 | 11.09 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 746.5588 | 8.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 747.5211 | 9.83 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 747.5219 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 748.5773 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 749.538 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 749.5383 | 10.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 750.5404 | 10.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 750.5914 | 9.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 750.637 | 7.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 751.4131 | 6.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 751.4155 | 6.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 751.4164 | 6.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 751.5428 | 9.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 753.2266 | 5.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 753.5393 | 10.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 755.5596 | 10.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 757.5257 | 8.7 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 761.5437 | 10.36 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 762.369 | 5.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 762.5868 | 9.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 763.5208 | 9.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 763.532 | 9.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 764.5736 | 8.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 765.5333 | 10.09 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 765.5413 | 10.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 765.5713 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 765.5776 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 766.583 | 8.25 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 767.5479 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 770.5589 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 773.5378 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 773.5992 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 774.3668 | 7.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 774.5947 | 9.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 775.5397 | 9.68 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 775.5452 | 9.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 775.5531 | 11.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 776.6033 | 10.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 777.5542 | 10.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 779.5696 | 11.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 781.4854 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 785.5207 | 11.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 786.5228 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 789.4953 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 789.5427 | 9.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 790.3589 | 7.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 791.5106 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 791.5477 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 791.548 | 10.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 791.5545 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 792.4782 | 8.29 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 793.4942 | 5.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 793.4959 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 793.5635 | 11.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 794.4912 | 8.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 794.5641 | 11.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 797.5577 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 799.5421 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 801.5561 | 9.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 801.6331 | 11.42 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 802.5522 | 8.71 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 803.5693 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 804.0797 | 8.81 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 806.3555 | 6.94 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 806.4876 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 807.5052 | 10.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 809.5083 | 10.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 809.5521 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 809.5923 | 11.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 811.5721 | 10.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 813.5832 | 10.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 815.4774 | 6.34 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 815.5104 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 815.5138 | 9.8 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 816.5647 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 817.5261 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 817.5864 | 10.63 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 818.4917 | 8.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 818.5152 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 818.5803 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 820.5055 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 821.4353 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 821.4573 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 822.5221 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 822.5726 | 11.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 823.448 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 823.4713 | 9.89 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 825.5515 | 9.45 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 827.5688 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 829.5827 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 831.5093 | 9.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 834.5253 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 834.6886 | 5.52 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 835.5349 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 835.5707 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 837.5818 | 10.24 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 837.5899 | 10.43 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 839.4436 | 10.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 839.5694 | 9.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 841.5206 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 841.5238 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 843.4857 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 843.5393 | 11.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 845.5415 | 10.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 846.4838 | 8.46 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 847.4519 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 847.5591 | 11.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 848.5019 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 849.4673 | 10.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 849.4888 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 850.5166 | 9.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 851.469 | 9.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 851.505 | 10.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 851.5666 | 9.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 851.5697 | 9.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 852.5223 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 853.5846 | 10.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 853.6621 | 11.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 857.5183 | 9.87 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 859.5011 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 859.5431 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 860.4621 | 8.28 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 860.5422 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 861.4264 | 9.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 861.6195 | 9.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 862.4719 | 8.56 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 863.4383 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 863.4457 | 9.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 863.6072 | 9.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 864.4458 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 867.474 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 871.5586 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 873.4651 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 873.5751 | 11.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 875.5644 | 9.27 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 876.5229 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 877.5826 | 9.88 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 879.4956 | 11.12 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 879.5929 | 10.76 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 879.5953 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 879.5989 | 10.19 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 883.4844 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 883.5058 | 10.33 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 884.5512 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 886.5177 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 888.4926 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 889.4538 | 10.39 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 890.4546 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 890.5024 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 891.4434 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 891.5121 | 9.47 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 895.556 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 896.5073 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 897.5702 | 10.3 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 899.5006 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 899.5193 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 903.4383 | 9.78 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 903.5013 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 905.5019 | 10.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 905.514 | 11.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 907.4624 | 10.96 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 911.6188 | 11.44 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 913.4616 | 10.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 914.5946 | 9.58 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 915.4453 | 10.06 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 916.4899 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 916.6077 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 916.6082 | 9.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 917.4551 | 10.4 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 919.5474 | 9.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 919.5555 | 9.8 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 920.4356 | 9.13 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 920.4504 | 9.49 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 920.5114 | 10.98 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 921.5715 | 10.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 923.3787 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 923.4866 | 9.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 923.498 | 9.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 923.5704 | 8.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 923.5858 | 11.08 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 925.6827 | 11.44 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 927.4914 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 927.4987 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 927.5257 | 10.66 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 929.413 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 931.4297 | 10.31 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 931.468 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 935.4619 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 937.4305 | 9.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 939.5299 | 10.23 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 941.5644 | 11.2 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 945.5704 | 9.86 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 945.7163 | 11.61 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 947.5774 | 10.22 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 947.586 | 10.74 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 948.4293 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 948.4417 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 948.4597 | 5.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 952.5374 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 954.5515 | 9.5 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 958.4912 | 9.48 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 959.4686 | 10.65 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 960.4287 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 962.6323 | 5.64 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 963.5406 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 965.4878 | 10.03 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 965.5534 | 10.11 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 966.6486 | 5.26 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 967.4011 | 10.97 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 968.4392 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 971.7302 | 11.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 975.6078 | 9.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 979.5571 | 9.17 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 979.5989 | 9.62 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 984.4698 | 9.14 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 987.5388 | 9.79 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 989.5587 | 10.12 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 993.5648 | 7.55 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 995.4891 | 10.02 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 998.6145 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1002.2588 | 7.32 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1014.6077 | 6.69 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1014.6081 | 6.93 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1023.6735 | 8.73 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1024.4639 | 9.15 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1025.6902 | 9.01 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1026.6127 | 5.04 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells | |
| AN003736 | 1034.7262 | 11.59 | Minutes | ST002285 | NEGATIVE | Agilent 6545 QTOF | Reversed phase | Human | Cultured cells |